Stephens & Co. Reiterates Overweight on Guardant Health, Maintains $210 Price Target

Benzinga · 1d ago
Stephens & Co. analyst Mason Carrico reiterates Guardant Health (NASDAQ:GH) with a Overweight and maintains $210 price target.